Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
Electromed
ELMD
$229M
| $5.04M | 0.01% |
173,004
-43,900
| -20% | -$1.15M |
2017 Q3
33 quarters
|
|
1302
Liberty Latin America Class A
LILA
$1.59B
| $5.02M | 0.01% |
999,869
+212,643
| +27% | +$1.17M |
2022 Q1
15 quarters
|
|
1303
State Street SPDR S&P Biotech ETF
XBI
$10B
| $5.01M | 0.01% |
+41,100
| New | +$4.71M |
2025 Q4
0 quarters
|
|
1304
First Horizon
FHN
$10.9B
| $5M | 0.01% |
209,411
-635,000
| -75% | -$14.2M |
2023 Q3
9 quarters
|
|
1305
Disc Medicine
IRON
$2.38B
| $4.99M | 0.01% |
62,820
+56,020
| +824% | +$4.73M |
2024 Q4
4 quarters
|
|
1306
NB Bancorp
NBBK
$969M
| $4.98M | 0.01% |
251,274
+140,374
| +127% | +$2.67M |
2024 Q1
7 quarters
|
|
|
ALEX
1307
DELISTED
Alexander & Baldwin
ALEX
| $4.97M | 0.01% |
240,731
-185,400
| -44% | -$3.22M |
2024 Q1
7 quarters
|
|
1308
Anika Therapeutics
ANIK
$262M
| $4.96M | 0.01% |
515,717
-17,300
| -3% | -$166K |
2013 Q2
50 quarters
|
|
1309
Select Water Solutions
WTTR
$2.55B
| $4.95M | 0.01% |
470,061
-212,015
| -31% | -$2.28M |
2019 Q3
25 quarters
|
|
1310
Sociedad Química y Minera de Chile
SQM
$18.3B
| $4.92M | 0.01% |
+71,584
| New | +$3.94M |
2025 Q4
0 quarters
|
|
1311
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.36B
| $4.92M | 0.01% |
+22,300
| New | +$4.85M |
2025 Q4
0 quarters
|
|
|
BRT
1312
BRT Apartments
BRT
$252M
| $4.91M | 0.01% |
334,091
-19,500
| -6% | -$288K |
2013 Q2
50 quarters
|
|
1313
ACM Research
ACMR
$4.97B
| $4.91M | 0.01% |
124,439
-175,486
| -59% | -$6.54M |
2025 Q2
2 quarters
|
|
|
HUYA
1314
Huya Inc
HUYA
$516M
| $4.91M | 0.01% |
1,704,100
-69,900
| -4% | -$205K |
2021 Q3
17 quarters
|
|
1315
East-West Bancorp
EWBC
$17.2B
| $4.9M | 0.01% |
43,633
+11,900
| +38% | +$1.26M |
2023 Q2
10 quarters
|
|
1316
Bassett Furniture
BSET
$181M
| $4.9M | 0.01% |
292,461
-26,900
| -8% | -$421K |
2013 Q2
50 quarters
|
|
1317
Acco Brands
ACCO
$414M
| $4.9M | 0.01% |
1,313,447
+321,400
| +32% | +$1.19M |
2021 Q4
16 quarters
|
|
|
CMRC
1318
Commerce.com Inc Series 1
CMRC
$288M
| $4.9M | 0.01% |
1,188,700
-40,200
| -3% | -$185K |
2021 Q4
16 quarters
|
|
1319
iShares Core S&P US Value ETF
IUSV
$27.7B
| $4.89M | 0.01% |
47,700
+9,400
| +25% | +$953K |
2025 Q2
2 quarters
|
|
1320
Immunocore
IMCR
$1.51B
| $4.89M | 0.01% |
140,900
-1,870
| -1% | -$66K |
2022 Q1
15 quarters
|
|
1321
Sonic Automotive
SAH
$1.91B
| $4.89M | 0.01% |
79,026
-15,274
| -16% | -$1.01M |
2023 Q1
11 quarters
|
|
1322
US Physical Therapy
USPH
$1.26B
| $4.87M | 0.01% |
62,374
-42,471
| -41% | -$3.45M |
2013 Q2
50 quarters
|
|
1323
Espey Mfg & Electronics Corp
ESP
$172M
| $4.87M | 0.01% |
103,312
+3,247
| +3% | +$130K |
2013 Q2
50 quarters
|
|
1324
Xeris Biopharma Holdings
XERS
$1.91B
| $4.86M | 0.01% |
619,660
-1,003,180
| -62% | -$7.9M |
2020 Q1
23 quarters
|
|
|
VTYX
1325
DELISTED
Ventyx Biosciences
VTYX
| $4.86M | 0.01% |
538,071
+303,071
| +129% | +$2.26M |
2024 Q3
5 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.